Home » Topics » Regulatory

Regulatory
RSS

Integrin antagonists useful for angiogenesis-related ocular diseases

Sep. 30, 2003

Thyrogen indication extended in Europe

Sep. 30, 2003

FDA advisory committee recommends expanded label for Provigil

Sep. 30, 2003

Lumiracoxib approved by the MHRA for osteoarthritis and other indications

Sep. 25, 2003

New formulation of Singulair available for young children with asthma

Sep. 25, 2003

Six-month priority review granted for Eloxatin sNDA

Sep. 22, 2003

Eisai submits E.U. Pariet application for on-demand therapy of symptomatic GERD

Sep. 22, 2003

FDA approves expanded Synagis labeling for children with congenital heart disease

Sep. 19, 2003

Cerezyme approved for type 3 Gaucher's disease in E.U.

Sep. 19, 2003

Valcyte approved for CMV prevention in transplant patients

Sep. 17, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...